Got $5,000 and 5 Years to Wait? Buy This Under-the-Radar Biotech Stock Now
Have you been looking for a growth stock that can supercharge your portfolio? It won't happen overnight, but there's a biotech stock flying under the radar that could turn $5,000 into a down payment for a new home in the not-so-far-off future.
BridgeBio Pharma (NASDAQ: BBIO) and its unique approach to the business of drug development is already showing signs of success, but its focus on genetic diseases hasn't seen much attention in 2020. Here are 3 reasons why you'll be hearing a lot more about BridgeBio and its soaring stock price in the years ahead.
Image source: Getty Images.
Source Fool.com
